Researchers Create Hybrid Malaria Parasite to Advance Whole-Parasite Vaccine Development
Source Summary
Researchers have engineered a hybrid malaria parasite combining the manufacturing efficiency of the strain currently used in all whole-parasite malaria vaccines with the superior liver infectivity of a recently collected East African parasite strain. The research, published in JCI Insight, aims to improve the effectiveness of whole-parasite vaccine development.
Why it matters
Combining manufacturing advantages with enhanced infectivity could improve the potency and scalability of whole-parasite malaria vaccines, addressing a major global health challenge affecting millions.
